Figure 2.
Frequency of grade ≥3 AEs. (A) All grade ≥3 nonhematologic AEs occurring in ≥5% of patients. (B) All grade ≥3 hematologic events. (C) All grade ≥3 infections. (D) Serial assessment of grade ≥3 AEs over time. The dashed line denotes 5% rate; time to onset is based on first occurrence of grade ≥3 event.